NATCO Pharma Limited
NATCO Pharma Limited appears in FDA public data with 2 recalls, 0 510(k) clearances, 9 FDA inspections, and 1 compliance action on record. Its most recent recall (D-0438-2024, Class II) was initiated on March 27, 2024.
Summary
- Total Recalls
- 2
- 510(k) Clearances
- 0
- Inspections
- 9
- Compliance Actions
- 1
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0438-2024 | Class II | Lansoprazole Delayed-Release Capsules USP, 15 mg, Acid reducer 24 Hour, Treats Frequent Heartburn, 1 | March 27, 2024 |
| D-0318-2024 | Class II | Lansoprazole Delayed-Release Capsules USP, 15 mg, 14-count bottle, Manufactured by: Natco Pharma Lim | February 1, 2024 |